A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci164918 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von David H McDermott und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes, Heterocyclic Compounds, Primary Immunodeficiency Diseases, Warts. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
- Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
- Laboratory of Cancer Biology and Genetics and.
- Laboratory of Cellular Oncology, National Cancer Institute.
- Department of Laboratory Medicine, Clinical Center.
- Office of the Clinical Director, National Institute of Dental and Craniofacial Research.
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
McDermott, D. H., Velez, D., Cho, E., Cowen, E. W., DiGiovanna, J. J., Pastrana, D. V., Buck, C. B., Calvo, K. R., Gardner, P. J., Rosenzweig, S. D., Stratton, P., Merideth, M. A., Kim, H. J., Brewer, C., Katz, J. D., Kuhns, D. B., Malech, H. L., Follmann, D., Fay, M. P., & Murphy, P. M. (2023). A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome. Journal of Clinical Investigation. https://doi.org/10.1172/jci164918
Vancouver
McDermott DH, Velez D, Cho E, Cowen EW, DiGiovanna JJ, Pastrana DV, et al. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome. Journal of Clinical Investigation. 2023. doi:10.1172/jci164918
BibTeX
@article{McDermott2023,
author = {McDermott, David H and Velez, Daniel and Cho, Elena and Cowen, Edward W and DiGiovanna, John J and Pastrana, Diana V and Buck, Christopher B and Calvo, Katherine R and Gardner, Pamela J and Rosenzweig, Sergio D and Stratton, Pamela and Merideth, Melissa A and Kim, H Jeffrey and Brewer, Carmen and Katz, James D and Kuhns, Douglas B and Malech, Harry L and Follmann, Dean and Fay, Michael P and Murphy, Philip M},
title = {A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci164918}
}
EUVIMED